L1CAM expression as a predictor of platinum response in high‐risk endometrial carcinoma

For high‐risk endometrial cancer (EC) patients, adjuvant chemotherapy is recommended to improve outcome. Yet, predictive biomarkers for response to platinum‐based chemotherapy (Pt‐aCT) are currently lacking. We tested expression of L1 cell‐adhesion molecule (L1CAM), a well‐recognised marker of poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Romani, Chiara, Capoferri, Davide, Reijnen, Casper, Lonardi, Silvia, Ravaggi, Antonella, Ratti, Martina, Bugatti, Mattia, Zanotti, Laura, Tognon, Germana, Sartori, Enrico, Odicino, Franco, Calza, Stefano, Pijnenborg, Johanna M. A., Bignotti, Eliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Tumor Markers and Signatures
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321598/
https://www.ncbi.nlm.nih.gov/pubmed/35429348
http://dx.doi.org/10.1002/ijc.34035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321598/
https://www.ncbi.nlm.nih.gov/pubmed/35429348
http://dx.doi.org/10.1002/ijc.34035

Ejemplares similares